ACTIVATION OF TUMOR-SPECIFIC CTLP TO A CYTOLYTIC STAGE REQUIRES ADDITIONAL SIGNALS

被引：0
|
作者：
VONHOEGEN, P
SCHIRRMACHER, V
机构：
来源：
ANNALS OF THE NEW YORK ACADEMY OF SCIENCES | 1988年 / 532卷
关键词：
D O I：
暂无
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：468 / 471
页数：4
相关论文
共 50 条
  • [41] Conversion of peripheral blood mononuclear cells into tumor-specific cytolytic cell populations using tumor cells engineered with multiple immunomodulatory factors
    Keegan, Joshua
    Lederer, James
    Borriello, Frank
    Schomer, Nathan
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [42] An enzyme-gated bioorthogonal catalytic nanoreactor for tumor-specific prodrug activation
    Guo, Yuheng
    Jiang, Fang
    Zhu, Xiaohui
    He, Wen
    Song, Sijie
    Shou, Xuecen
    Wu, Mengnan
    Wu, Ting
    Huang, Tingjing
    Ye, Zhi
    Wang, Xuyang
    Chen, Zhitong
    He, Yu
    Yao, Yuhang
    Chen, Zhaowei
    Yang, Huanghao
    NANO RESEARCH, 2025, 18 (02)
  • [43] Parameters involved in the recognition of fresh human leukemic blasts by tumor-specific cytolytic T cell clones: a model study
    Chambost, H
    Collette, Y
    Dutartre, H
    Thuret, I
    Olive, D
    LEUKEMIA RESEARCH, 2000, 24 (10) : 823 - 830
  • [44] Derivation of tumor-specific cytolytic T-cell clones from two lung cancer patients with long survival
    Weynants, P
    Thonnard, J
    Marchand, M
    Delos, M
    Boon, T
    Coulie, PG
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1999, 159 (01) : 55 - 62
  • [45] Induction of tumor-specific cytolytic activity by B7-1 gene transfer into human hepatocellular carcinoma.
    Tatsumi, T
    Takehara, T
    Kanto, T
    Yamamoto, M
    Sasaki, Y
    Kasahara, A
    Hayashi, N
    HEPATOLOGY, 1996, 24 (04) : 45 - 45
  • [46] The shaved tumor-specific antigen encoded by mouse gene P1A is a target not only for cytolytic T lymphocytes but also for tumor rejection
    Brändle, D
    Bilsborough, J
    Rülicke, T
    Uyttenhove, C
    Boon, T
    Van den Eynde, BJ
    EUROPEAN JOURNAL OF IMMUNOLOGY, 1998, 28 (12) : 4010 - 4019
  • [47] ENHANCED TUMOR-GROWTH AND SUPPRESSION OF THE TUMOR-SPECIFIC CYTOLYTIC LYMPHOCYTE-T RESPONSE IN MICE CHRONICALLY INFECTED BY TRYPANOSOMA-CRUZI
    PLATA, F
    MILON, G
    MARCHAL, G
    PONS, FG
    EISEN, H
    IMMUNOBIOLOGY, 1984, 167 (1-3) : 217 - 217
  • [48] PROGRESSOR VARIANTS OF A REGRESSOR TUMOR SELECTED INVITRO WITH CYTOLYTIC T-CELL CLONES FOR LOSS OF DEFINED COMPONENTS OF A COMPLEX TUMOR-SPECIFIC ANTIGEN
    WORTZEL, RD
    URBAN, JL
    SCHREIBER, H
    PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, 1983, 24 (MAR): : 236 - 236
  • [49] Flexible and sensitive method to functionally validate tumor-specific receptors via activation of NFAT
    Schaft, N
    Lankiewicz, B
    Gratama, JW
    Bolhuis, RLH
    Debets, R
    JOURNAL OF IMMUNOLOGICAL METHODS, 2003, 280 (1-2) : 13 - 24
  • [50] Prodrug-Based Nanoreactors with Tumor-Specific In Situ Activation for Multisynergistic Cancer Therapy
    Ren, Cui
    Liu, Huifang
    Lv, Fangfang
    Zhao, Wencong
    Gao, Shutao
    Yang, Xinjian
    Jin, Yi
    Tan, Yanli
    Zhang, Jinchao
    Liang, Xing-Jie
    Li, Zhenhua
    ACS APPLIED MATERIALS & INTERFACES, 2020, 12 (31) : 34667 - 34677
12345